SINGAPORE (March 16): In a country where cannabis – commonly also known as marijuana, weed or pot – is recognised as a Class A controlled drug, a bio-technology company is seeking to pursue opportunities in a sector where its medicinal use is legalised.

Incorporated in Singapore and listed on the Australian Securities Exchange (ASX), Stemcell United (SCU) was founded by Australian CEO and executive director Gu Huan Qing in 2014.

According to its website, the company focuses on the growth, reproduction, culture and extraction of stem cells for medicinal, health and beauty applications. Its main products comprise two active plant extracts, namely Dendrobium Officinale and Daemonorops Draco Blume.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
Related Stories

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook